NEW YORK, Jan 5 – Proteomics company Structural Bioinformatics said Friday it has appointed Ian McDonald as vice president of drug discovery.
McDonald was previously senior director of chemistry at Merck Research Laboratories. He is an inventor on 32 patents in the US.
" Over the past few years, SBI has consistently demonstrated its unique ability to efficiently generate initial hits from in silico screening of virtual libraries against modeled protein structures,” McDonald said in a statement.
“I am pleased to join SBI to expand its leadership position in drug discovery as we expand our wet lab capabilities to advance these novel hits towards clinical validation,” he added.
SBI, a privately held company based in San Diego, has develops technologies to
generate 3-dimensional structural models of proteins from genetic information.